Lixte Biotechnology Holdings Cash from Financing (TTM) Insights

Lixte Biotechnology Holdings Inc (LIXT)

2.95 +0.06 (+2.08%) USD | NASDAQ | May 06, 16:00

2.95 0.00 (0.00%) After-Hours: 18:02

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2006. Upgrade now.

Date	Value
December 31, 2023	3.143M
September 30, 2023	3.143M
June 30, 2023	0.0063M
March 31, 2023	5.159M
December 31, 2022	5.141M
September 30, 2022	5.151M
June 30, 2022	5.241M
March 31, 2022	0.1901M
December 31, 2021	3.897M
September 30, 2021	8.620M
June 30, 2021	8.455M
March 31, 2021	8.298M
December 31, 2020	4.602M
September 30, 2020	-0.1302M
June 30, 2020	-0.0559M
March 31, 2020	0.00
December 31, 2019
September 30, 2019
June 30, 2019
March 31, 2019
December 31, 2018
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017	2.518M

Date	Value
September 30, 2017	2.518M
June 30, 2017	2.50M
March 31, 2017	1.581M
December 31, 2016	1.748M
September 30, 2016	1.748M
June 30, 2016	1.748M
March 31, 2016	1.482M
December 31, 2015	2.052M
September 30, 2015	2.052M
June 30, 2015	2.052M
March 31, 2015	3.150M
December 31, 2014	1.412M
September 30, 2014	1.412M
June 30, 2014	1.412M
March 31, 2014	0.00
December 31, 2013	0.00
September 30, 2013	0.00
June 30, 2013	0.00
March 31, 2013	2.468M
December 31, 2012	2.502M
September 30, 2012	2.502M
June 30, 2012	2.502M
March 31, 2012	0.0383M
December 31, 2011	0.005M
September 30, 2011	0.005M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.1302M

Minimum

Sep 2020

8.620M

Maximum

Sep 2021

3.804M

Average

4.250M

Median

Cash from Financing (TTM) Benchmarks